1,389 reports of this reaction
3.6% of all BISACODYL SUPPOSITORIES reports
#1 most reported adverse reaction
CONSTIPATION is the #1 most commonly reported adverse reaction for BISACODYL SUPPOSITORIES, manufactured by Oncor Pharmaceuticals. There are 1,389 FDA adverse event reports linking BISACODYL SUPPOSITORIES to CONSTIPATION. This represents approximately 3.6% of all 38,233 adverse event reports for this drug.
Patients taking BISACODYL SUPPOSITORIES who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONSTIPATION is moderately reported among BISACODYL SUPPOSITORIES users, representing a notable but not dominant share of adverse events.
In addition to constipation, the following adverse reactions have been reported for BISACODYL SUPPOSITORIES:
The following drugs have also been linked to constipation in FDA adverse event reports:
CONSTIPATION has been reported as an adverse event in 1,389 FDA reports for BISACODYL SUPPOSITORIES. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONSTIPATION accounts for approximately 3.6% of all adverse event reports for BISACODYL SUPPOSITORIES, making it one of the most commonly reported side effect.
If you experience constipation while taking BISACODYL SUPPOSITORIES, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.